for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Sino Biopharmaceutical Limited

1177.HK

Latest Trade

8.93HKD

Change

0.02(+0.22%)

Volume

42,298,745

Today's Range

8.81

 - 

9.00

52 Week Range

6.17

 - 

11.24

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Sino Biopharmaceutical Says "Spironolactone Tablets" Obtained Notice Of Approval By NMPA Of PRC

Sept 15 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::SINO BIOPHARMACEUTICAL ANNOUNCES THAT "SPIRONOLACTONE TABLETS" OBTAINED NOTICE OF APPROVAL OF SUPPLEMENTAL APPLICATIONS ISSUED BY NMPA OF PRC.

Sino Biopharmaceutical Says "Saxaglipin Tablets" Got Drug Registration Certificate From NMPA

Sept 14 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::"SAXAGLIPIN TABLETS" GOT DRUG REGISTRATION CERTIFICATE GRANTED BY NMPA OF PRC.

Sino Biopharmaceutical Says "TDI01" Clinical Trial Application Accepted By CDE Of PRC

Sept 2 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::CLINICAL TRIAL APPLICATION FOR INNOVATIVE MEDICINE "TDI01" ACCEPTED BY CENTER FOR DRUG EVALUATION OF PRC.

Sino Biopharmaceutical Posts HY Profit Attributable RMB1,213.08 Mln, Down 16.0%

Aug 28 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::HY PROFIT ATTRIBUTABLE RMB1,213.08 MILLION, DOWN 16.0%.DECLARED QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE FOR PERIOD ENDED 30 JUNE.HY REVENUE RMB12,647.78 MILLION, UP 1.0%.

Sino Biopharmaceutical Says Tse Ping Resigned As Chief Executive Officer

Aug 19 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::TSE PING HAS RESIGNED AS CHIEF EXECUTIVE OFFICER.TSE PING REDESIGNATED AS SENIOR VICE CHAIRMAN OF BOARD.LI YI HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER.

Sino Biopharmaceutical Announces Passing Of Consistency Evaluation For Adefovir Dipivoxil Capsules By NMPA

Aug 4 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::SINO BIOPHARMACEUTICAL ANNOUNCES PASSING OF CONSISTENCY EVALUATION FOR ADEFOVIR DIPIVOXIL CAPSULES BY NMPA.

Sino Biopharmaceutical Says "Tofacitinib Citrate Tablet" Obtained Drug Registration Certificate Granted By NMPA

July 31 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::"TOFACITINIB CITRATE TABLET" OBTAINED DRUG REGISTRATION CERTIFICATE GRANTED BY NMPA.

Sino Biopharmaceutical Says Apixaban Tablet Obtained Drug Registration Certificate By Nmpa

July 30 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::SINO BIOPHARMACEUTICAL LTD - APIXABAN TABLET OBTAINED DRUG REGISTRATION CERTIFICATE BY NMPA.

Sino Biopharmaceutical Says Idarubicin Hydrochloride For Injection Obtains Approval For Drug Registration From NMPA

July 29 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::IDARUBICIN HYDROCHLORIDE FOR INJECTION OBTAINS APPROVAL FOR DRUG REGISTRATION FROM NMPA.

Sino Biopharmaceutical Says A Company Onwed By CEO Entered Into A Placing Agreement With Third Parties Independent From Co

July 24 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::SINO BIOPHARMACEUTICAL LTD - A COMPANY ONWED BY CEO ENTERED INTO A PLACING AGREEMENT WITH THIRD PARTIES INDEPENDENT FROM CO.SINO BIOPHARMACEUTICAL- DOES NOT EXPECT PLACING TO HAVE ANY IMPACT ON BUSINESS OR OPERATIONS OF CO; COMPOSITION OF BOARD REMAINS UNCHANGED.SINO BIOPHARMACEUTICAL- PLACING AGREEMENT TO PROCURE PLACEES TO PURCHASE FOR 300 MILLION SHARES OF COMPANY AT HK$10.5 PER SHARE.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up